ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,183Medicare Part D Prescriptions Filled, Including Refills

Rank: 289 out of 3593

$1.57M Total Retail Price of All Prescriptions

Rank: 40 out of 3593

867 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 867 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 11,516 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

50% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$111 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
IBUPROFEN 1,274 1,023 10 1 43
LIDODERM 755 616 2 78
AMMONIUM LACTATE 488 401 3 125
ADVAIR DISKUS 445 314 4 47
VOLTAREN 437 352 5 85
SINGULAIR 436 355 6 77
CRESTOR 391 286 7 21
NEXIUM 340 242 8 36
SPIRIVA 330 280 9 87
LISINOPRIL 303 265 10 2
AMLODIPINE BESYLATE 302 260 11 3
CELEBREX 299 198 12 100
NASONEX 284 213 13 192
OMEPRAZOLE 245 188 14 5
METFORMIN HCL 225 191 15 6
SIMVASTATIN 208 179 16 1
FLOVENT HFA 175 159 17 303
PENTOXIFYLLINE 174 161 18 149
HYDROCHLOROTHIAZIDE 151 124 19 10
DICLOFENAC SODIUM 148 117 20 74
LOVAZA 147 133 21 106
NAPROXEN 145 117 22 68
PLAVIX 143 117 23 42
ATENOLOL 142 129 24 11
KETOCONAZOLE 139 132 25 118
RANITIDINE HCL 123 115 26 27
MONTELUKAST SODIUM 122 97 27 151
DIOVAN 121 115 28 46
LEVOTHYROXINE SODIUM 116 105 29 4
FLOVENT DISKUS 111 94 10 30 517
FUROSEMIDE 110 82 31 9
DEXILANT 108 99 32 222
CLOPIDOGREL 101 86 33 30
ATROVENT HFA 101 68 33 439
LANSOPRAZOLE 96 66 35 113
LANTUS 95 88 36 57
METOPROLOL TARTRATE 92 63 37 8
MECLIZINE HCL 91 86 38 96
METOPROLOL SUCCINATE 87 73 39 19
LOSARTAN POTASSIUM 87 50 39 14
HYDROXYZINE PAMOATE 87 64 R 39 369
CANASA 81 65 10 42 537
ENALAPRIL MALEATE 78 67 43 38
COMBIVENT 75 53 44 161
INSULIN SYRINGE 74 62 45 91
CLOBETASOL PROPIONATE 74 65 45 187
NOVOLIN 70-30 73 73 47 146
CIPROFLOXACIN HCL 73 58 47 52
FLUTICASONE PROPIONATE 72 63 49 32
SURE COMFORT 67 67 50 159
TRIAMTERENE-HCTZ 66 58 51 66
DIOVAN HCT 64 64 52 76
PROAIR HFA 62 54 53 54
GLIPIZIDE 60 54 54 40
DESONIDE 59 48 55 315
LISINOPRIL-HYDROCHLOROTHIAZIDE 59 53 55 26
TRICOR 58 42 57 130
TESTOSTERONE CYPIONATE 56 45 S3 58 289
TRIAMCINOLONE ACETONIDE 54 49 59 119
METOCLOPRAMIDE HCL 53 37 60 145
GLYBURIDE-METFORMIN HCL 52 45 R 61 95
ASTEPRO 52 39 61 593
HYDROCORTISONE 51 34 63 273
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 2, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.